LKFT peer analysis
Lakefront Biotherapeutics (LKFT) against its competitors: price, today's move, 1-year return and market value side by side.
LKFT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AURA Aura Biosciences | $7.66 | 0.00% | 43.18% | $794.38M |
| CBIO Crescent Biopharma | $13.85 | 1.47% | 5.48% | $514.44M |
| GNLX Genelux | $2.07 | 5.61% | -61.81% | $93.66M |
| IOVA Iovance | $8.08 | -1.10% | 251.30% | $3.66B |
| MLTX MoonLake | $12.57 | -0.40% | 18.25% | $1.07B |
| NBP NovaBridge Biosciences | $0.91 | -0.08% | -77.28% | $104.75M |
| SLS SELLAS Life Sciences | $8.43 | -1.81% | 429.87% | $1.70B |
| SNDX Syndax Pharmaceuticals | $9.46 | -0.94% | -37.10% | $851.67M |
| STTK Shattuck Labs | $4.85 | -2.81% | 144.95% | $486.76M |
| TRAX First Tracks Biotherapeutics | $52.27 | 5.17% | – | $2.20B |
| LKFT Lakefront Biotherapeutics | $33.52 | 0.21% | – | $2.20B |
- LKFT's peers: AURA (Aura Biosciences), CBIO (Crescent Biopharma), GNLX (Genelux), IOVA (Iovance), MLTX (MoonLake), NBP (NovaBridge Biosciences), SLS (SELLAS Life Sciences), SNDX (Syndax Pharmaceuticals).
Updated 2026-11-11 00:49 UTC